Monoclonal gammopathy and Agranulocytosis


Agranulocytosis is found among people with Monoclonal gammopathy, especially for people who are female, 60+ old.

The study analyzes which people have Agranulocytosis with Monoclonal gammopathy. It is created by eHealthMe based on reports of 12 people who have Monoclonal gammopathy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2022

12 people who have Monoclonal Gammopathy and Agranulocytosis are studied.

What is Monoclonal gammopathy?

Monoclonal gammopathy is found to be associated with 425 drugs and 201 conditions by eHealthMe.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 3,083 drugs and 3,325 conditions by eHealthMe.

Number of Agranulocytosis in Monoclonal gammopathy reports submitted per year:

Would you have Agranulocytosis when you have Monoclonal gammopathy?

Gender of people who have Monoclonal Gammopathy and experienced Agranulocytosis *:

  • female: 54.55 %
  • male: 45.45 %

Age of people who have Monoclonal Gammopathy and experienced Agranulocytosis *:

  • 0-1: 0.0 %
  • 2-9: 42.86 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 57.14 %

Common co-existing conditions for these people *:

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 41.67%
  2. Multiple Myeloma (cancer of the plasma cells): 3 people, 25.00%
  3. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 16.67%
  4. Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 16.67%
  5. Seasonal Allergy (allergic condition due to certain season): 2 people, 16.67%
  6. Hypergammaglobulinaemia Benign Monoclonal (elevated levels of gamma globulin): 2 people, 16.67%
  7. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 1 person, 8.33%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 8.33%
  9. Anaemia (lack of blood): 1 person, 8.33%
  10. Bradycardia (abnormally slow heart action): 1 person, 8.33%

Common drugs taken by these people *:

  1. Revlimid: 7 people, 58.33%
  2. Multivitamin: 3 people, 25.00%
  3. Zyrtec: 2 people, 16.67%
  4. Valacyclovir: 2 people, 16.67%
  5. Darzalex: 2 people, 16.67%
  6. Vitamin D3: 2 people, 16.67%
  7. Methotrexate: 1 person, 8.33%
  8. Cyclophosphamide: 1 person, 8.33%
  9. Detrol La: 1 person, 8.33%
  10. Eprex: 1 person, 8.33%

Common symptoms for these people *:

  1. Weakness: 3 people, 25.00%
  2. Fever: 3 people, 25.00%
  3. Hepatic Enzyme Increased: 3 people, 25.00%
  4. Mucosal Inflammation (infection of mucous membrane): 3 people, 25.00%
  5. Cryptococcal Fungaemia (presence of fungi or yeasts in the blood): 3 people, 25.00%
  6. Feeling Abnormal: 2 people, 16.67%
  7. Bk Virus Infection: 2 people, 16.67%
  8. Full Blood Count Decreased: 2 people, 16.67%
  9. Depression: 1 person, 8.33%
  10. Fatigue (feeling of tiredness): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Agranulocytosis?

Check whether Agranulocytosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Treatments, associated drugs and conditions:

COVID vaccines that are related to Agranulocytosis:

Common drugs associated with Agranulocytosis:

All the drugs that are associated with Agranulocytosis:

Common conditions associated with Agranulocytosis:

All the conditions that are associated with Agranulocytosis:

How the study uses the data?

The study is based on Agranulocytosis and Monoclonal gammopathy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: